Drug-drug interactions of new active substances: mibefradil example.
Siepmann
M
M
Kirch
W
W
D004077:Digoxin / Q000493:pharmacokinetics; D004347:Drug Interactions; D006801:Humans; D020748:Mibefradil / Q000009:adverse effects*
D020748:Mibefradil; D004077:Digoxin